211 EFFECTS OF RADIOFREQUENCY ABLATION (RFA) IN COMBINATION WITH SORAFENIB IN A 2-TUMOR RAT MODEL OF HEPATOCELLULAR CARCINOMA
Caroline Hora(University of Bern), Andreas Geier(Swiss Integrative Center for Human Health), S. Mertens(University Hospital Zurich), Anne‐Christine Piguet(University of Bern), Joachim Kettenbach(Harvard University Press), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Jean‐François Dufour(Universidad Iberoamericana), M Ledermann(University of Bern), J. Schmitt(University Hospital Zurich), Bettina Saar
Cited by 1
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k